Reply
Open Access
- 15 May 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 183 (10) , 1539-1540
- https://doi.org/10.1086/320207
Abstract
To the Editor —We appreciate the letter from Parienti et al. [1] regarding our study [2] on once-daily combination therapy with emtricitabine, didanosine, and efavirenz in human immunodeficiency virus (HIV)–infected patients. Parienti et al. bring to our attention their concern that once-daily regimens may increase drug holidays, thereby favoring the emergence of viral resistance and, eventually, of treatment failureKeywords
This publication has 0 references indexed in Scilit: